Linda Makowska Rasmussen

Linda Makowska Rasmussen serves as Clinical Associate Professor within the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Her clinical-academic role bridges hospital practice at the Capital Region of Denmark (regionh.dk) with university research activities, focusing on evidence-based respiratory medicine.

Her research program centers on severe asthma therapeutics, particularly examining real-world impacts of biologic therapies on productivity loss, workforce attachment, and corticosteroid exposure patterns. Key methodologies include nationwide cohort studies, randomized controlled trials (e.g., OPTIMAL study), and genetic association analyses. Recent work demonstrates significant contributions to understanding treatment optimization through longitudinal data spanning 27 years.

Publication trends reveal consistent high-impact output in respiratory journals, with notable citations including 664 for the 2009 Nature Genetics paper linking eosinophil genetics to asthma and myocardial infarction. Current research (2024-2025) emphasizes health economics aspects of biologic therapies and workforce outcomes, reflecting evolving priorities in respiratory medicine.

Collaboration networks span major Danish hospitals and research centers, with frequent co-authorship among respiratory specialists including C. S. Ulrik, C. Porsbjerg, and M. B. Søndergaard. The research group maintains strong ties to European Respiratory Society publication channels and leverages national healthcare registries for population-level analyses.